-
Acorda Therapeutics Completes Exchange of $276 Million of its 1.75% Convertible Senior Notes
Post on 1/1/20
-
Cellular Biomedicine Group Announces Engagement of Independent Advisors by Special Committee
Post on 1/1/20
-
Axsome Therapeutics Closes $200M Public Offering of Common Stock
Post on 1/1/20
-
Abeona Closes $103.5M Underwritten Public Offering
Post on 1/1/20
-
Starton Therapeutics: Announcing Name Change for ChemioCare
Post on 1/1/20
-
Melinta Therapeutics Announces Restructuring Support Agreement with its Secured Lenders
Post on 1/1/20
-
Outlook Therapeutics Announces Completion of Warrant Restructuring
Post on 1/1/20
-
These Were the 10 Best Healthcare Stocks of 2019
Post on 12/24/19
-
Athenex Mixed Results, Boston Scientific Approval, And Other News: The Good, Bad, And Ugly Of Biopharma
Post on 12/23/19
-
Bioasis Completes Bridge Financing Transaction
Post on 12/23/19
-
Avalon GloboCare Partners with China Cell Valley
Post on 12/23/19
-
Hoth Therapeutics Issues 2019 Shareholder Letter
Post on 12/23/19
-
Acorda Therapeutics Announces Private Exchange of $276 Million of Its 1.75% Convertible Senior Notes
Post on 12/23/19
-
How Gilead Sciences Is Helping Fund Bristol-Myers Squibb's Celgene Acquisition
Post on 12/23/19
-
Better Buy: Amgen vs. Johnson & Johnson
Post on 12/23/19
-
Abeona Therapeutics Announces Public Offering of Common Stock
Post on 12/20/19
-
Axsome Therapeutics Announces Proposed Public Offering of Common Stock
Post on 12/20/19
-
Axsome Therapeutics Prices Public Offering of $174M of Shares of Common Stock
Post on 12/20/19
-
CytoDyn Signs Definitive Agreements with Vyera Pharmaceuticals
Post on 12/20/19
-
Johnson & Johnson To Acquire Remainder Of Verb Surgical
Post on 12/20/19
-
Hoth Therapeutics Enters into Research Collaboration Agreement with Weill Cornell Medicine
Post on 12/19/19
-
Turnstone Biologics Announces Global Collaboration and License Agreement with Takeda
Post on 12/19/19
-
Cara Therapeutics: Recent Stock Price Plunge Was A Bit Exaggerated
Post on 12/19/19
-
How Big of a Deal Is Axsome Therapeutics' New Depression Drug?
Post on 12/18/19
-
Teva Avoids Bankruptcy, Huge Upside
Post on 12/18/19